506 related articles for article (PubMed ID: 34517046)
1. Coronavirus disease 2019 and the gut-lung axis.
Zhou D; Wang Q; Liu H
Int J Infect Dis; 2021 Dec; 113():300-307. PubMed ID: 34517046
[TBL] [Abstract][Full Text] [Related]
2. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
Xiang H; Liu QP
World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
[TBL] [Abstract][Full Text] [Related]
3. Roles of the gut microbiota in severe SARS-CoV-2 infection.
Liu Y; Kuang D; Li D; Yang J; Yan J; Xia Y; Zhang F; Cao H
Cytokine Growth Factor Rev; 2022 Feb; 63():98-107. PubMed ID: 35131164
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications.
Zhang F; Lau RI; Liu Q; Su Q; Chan FKL; Ng SC
Nat Rev Gastroenterol Hepatol; 2023 May; 20(5):323-337. PubMed ID: 36271144
[TBL] [Abstract][Full Text] [Related]
5. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
Front Immunol; 2021; 12():635471. PubMed ID: 33717181
[TBL] [Abstract][Full Text] [Related]
6. Impact of COVID-19 on the Intestinal Microbiome.
Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus disease-2019 and the intestinal tract: An overview.
Alberca GGF; Solis-Castro RL; Solis-Castro ME; Alberca RW
World J Gastroenterol; 2021 Apr; 27(13):1255-1266. PubMed ID: 33833480
[TBL] [Abstract][Full Text] [Related]
8. Premises among SARS-CoV-2, dysbiosis and diarrhea: Walking through the ACE2/mTOR/autophagy route.
de Oliveira AP; Lopes ALF; Pacheco G; de Sá Guimarães Nolêto IR; Nicolau LAD; Medeiros JVR
Med Hypotheses; 2020 Nov; 144():110243. PubMed ID: 33254549
[TBL] [Abstract][Full Text] [Related]
9. Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID.
Ancona G; Alagna L; Alteri C; Palomba E; Tonizzo A; Pastena A; Muscatello A; Gori A; Bandera A
Front Immunol; 2023; 14():1080043. PubMed ID: 36969243
[TBL] [Abstract][Full Text] [Related]
10. The Role of the Gut-Lung Axis in COVID-19 Infections and Its Modulation to Improve Clinical Outcomes.
Chen J; Vitetta L
Front Biosci (Schol Ed); 2022 Aug; 14(3):23. PubMed ID: 36137978
[TBL] [Abstract][Full Text] [Related]
11. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
12. Cross-talk between immune system and microbiota in COVID-19.
Baradaran Ghavami S; Pourhamzeh M; Farmani M; Raftar SKA; Shahrokh S; Shpichka A; Asadzadeh Aghdaei H; Hakemi-Vala M; Hossein-Khannazer N; Timashev P; Vosough M
Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1281-1294. PubMed ID: 34654347
[TBL] [Abstract][Full Text] [Related]
13. Intermodulation of gut-lung axis microbiome and the implications of biotics to combat COVID-19.
S A; K G; A AM
J Biomol Struct Dyn; 2022; 40(24):14262-14278. PubMed ID: 34699326
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 as a trigger of irritable bowel syndrome: A review of potential mechanisms.
Settanni CR; Ianiro G; Ponziani FR; Bibbò S; Segal JP; Cammarota G; Gasbarrini A
World J Gastroenterol; 2021 Nov; 27(43):7433-7445. PubMed ID: 34887641
[TBL] [Abstract][Full Text] [Related]
15. COVID-19: gastrointestinal symptoms from the view of gut-lung axis.
Zhang M; Zhou Y; Li H; Peng Y; Qiu P; Shi X; Pan X; Liu J
Eur J Gastroenterol Hepatol; 2021 May; 33(5):610-612. PubMed ID: 33136724
[TBL] [Abstract][Full Text] [Related]
16. Potential role of the microbiome in liver injury during COVID-19: Further research is needed.
Tovani-Palone MR; Pedersini P
World J Gastroenterol; 2023 Jan; 29(3):503-507. PubMed ID: 36688015
[TBL] [Abstract][Full Text] [Related]
17. Gut distress and intervention
Moon Y
Front Public Health; 2023; 11():1098774. PubMed ID: 37139365
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and Covid-19- possible link and implications.
Dhar D; Mohanty A
Virus Res; 2020 Aug; 285():198018. PubMed ID: 32430279
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
Viruses; 2023 May; 15(6):. PubMed ID: 37376531
[TBL] [Abstract][Full Text] [Related]
20. The pathophysiological mechanisms of COVID-19 and host immunity, with emphasis on the dysbiosis of the lung and gut microbiomes and pregnancy.
Asai N; Kato H; Mikamo H
Respir Investig; 2022 Jul; 60(4):496-502. PubMed ID: 35422403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]